Globe Life Inc. (NYSE:GL) Shares Sold by Xponance Inc.

Xponance Inc. decreased its holdings in shares of Globe Life Inc. (NYSE:GL) by 12.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 11,059 shares of the company’s stock after selling 1,579 shares during the period. Xponance Inc.’s holdings in Globe Life were worth $1,346,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of GL. Private Trust Co. NA lifted its stake in shares of Globe Life by 270.0% in the fourth quarter. Private Trust Co. NA now owns 222 shares of the company’s stock valued at $27,000 after purchasing an additional 162 shares during the period. BKM Wealth Management LLC acquired a new stake in shares of Globe Life during the 4th quarter valued at approximately $28,000. Bruce G. Allen Investments LLC purchased a new stake in shares of Globe Life during the 4th quarter worth approximately $63,000. First Command Advisory Services Inc. acquired a new stake in shares of Globe Life in the 3rd quarter worth approximately $61,000. Finally, Annis Gardner Whiting Capital Advisors LLC purchased a new position in Globe Life in the 3rd quarter valued at approximately $71,000. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Price Performance

NYSE:GL opened at $78.60 on Thursday. Globe Life Inc. has a 12-month low of $38.95 and a 12-month high of $132.00. The firm has a market cap of $7.39 billion, a price-to-earnings ratio of 7.51 and a beta of 0.69. The company’s 50-day moving average is $108.65 and its two-hundred day moving average is $115.82. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.36.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Monday, April 22nd. The company reported $2.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.79 by ($0.01). The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.42 billion. Globe Life had a net margin of 18.07% and a return on equity of 23.91%. The business’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the company posted $2.53 EPS. Research analysts expect that Globe Life Inc. will post 11.6 EPS for the current year.

Globe Life Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Friday, April 5th will be paid a $0.24 dividend. This is a positive change from Globe Life’s previous quarterly dividend of $0.23. This represents a $0.96 annualized dividend and a yield of 1.22%. The ex-dividend date of this dividend is Thursday, April 4th. Globe Life’s dividend payout ratio is presently 9.17%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on GL shares. Evercore ISI decreased their target price on Globe Life from $125.00 to $75.00 and set an “in-line” rating on the stock in a research report on Friday, April 12th. Truist Financial lowered their price objective on shares of Globe Life from $125.00 to $80.00 and set a “hold” rating on the stock in a research note on Wednesday. JPMorgan Chase & Co. raised their target price on shares of Globe Life from $133.00 to $136.00 and gave the company an “overweight” rating in a report on Thursday, February 8th. Keefe, Bruyette & Woods raised shares of Globe Life from a “market perform” rating to an “outperform” rating and reduced their price target for the company from $130.00 to $110.00 in a report on Wednesday. Finally, Wells Fargo & Company lowered their price target on shares of Globe Life from $132.00 to $108.00 and set an “overweight” rating on the stock in a research report on Wednesday. Five research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $114.33.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.